Accuracy of wavefront aberrometry in cataract patients

Article

Loss of optical media transperency reduces accuracy in clinical practice

Wavefront aberrometry (WA) offers promising applications in ophthalmology and can provide valuable information in previously underresearched conditions including hyperopia and cataract-related reduced visual acuity (VA). In clinical settings, WA is frequently used to assess patients presenting for refractive surgery, and previous studies have demonstrated a high level of accuracy of WA measurements in comparison to those of manifest refraction (MR) and autorefraction. However, the subjects of these studies have primarily been young, myopic and well-sighted patients, while in clinical practice the majority of patients presenting for cataract surgery are of advanced age, with ametropia and reduced VA.

As a patient's VA can be affected when WA is used as a basis for surgical treatment of pathological conditions (particularly if the measurements are less accurate in specific patient populations), Dr Stephan Linke, Dr Jan Hülle (University Medical Center HamburgEppendorf, Germany) and colleagues decided to conduct a study to evaluate the accuracy of WA in comparison to MR in an older population awaiting cataract surgery.1 The trial was intended to help the team determine if previous study results can be replicated in clinical practice and to establish which factors, if any, affect the accuracy of the refractive values as measured by WA.

Assessing the eyes

"We had anticipated that WA would measure the same refractive values as MR, but that potential measurement differences between the devices would be explained either by the refractive state - hyperopia versus myopia - or by age. We also thought that the only impact of cataract on the results would be that more progressed forms of cataract would lead to more exaggerated differences between measurements taken on the separate devices," explained Dr Hülle. "However, some of the results we actually achieved were surprising, and were in fact contrary to previously published conclusions."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.